Clinical Trial of Sinudrain Haft Bahr Solution for Symptom Management in Mild to Moderate COVID-19
Introduction: The COVID-19 pandemic, caused by the coronavirus, has been declared a global health emergency by the World Health Organization (WHO). This virus primarily affects the respiratory system, and affordable treatments for mild to moderate cases are urgently needed. Sinudrain Haft Bahr, a so...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SBMU Journals
2024-01-01
|
| Series: | Archives of Advances in Biosciences |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|